Publicaciones en colaboración con investigadores/as de Queen's University (2)

2018

  1. Outcomes of single versus double hormone receptor–positive breast cancer. A GEICAM/9906 sub-study

    European Journal of Cancer, Vol. 94, pp. 199-205

2015

  1. Lapatinib or trastuzumab plus taxane therapy for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results of NCIC CTG MA.31

    Journal of Clinical Oncology, Vol. 33, Núm. 14, pp. 1574-1583